The SCICONX Journal of Immunity and Infectious Diseases (JIID) serves as a premier international forum for advancing research, knowledge exchange, and innovation in the fields of immunology, infectious diseases, and global health preparedness. The journal’s mission is to bridge foundational science with clinical and public health practice, fostering discoveries that address both current and emerging health threats worldwide.

✨ Aim

The aim of JIID is to:

• Promote cutting-edge research that deepens understanding of immune mechanisms and their role in disease prevention and treatment.
• Facilitate multidisciplinary dialogue among immunologists, microbiologists, virologists, epidemiologists, clinicians, and policymakers.
• Support the translation of laboratory findings into clinical and community-based solutions, enabling timely interventions for infectious disease management.
• Provide a platform for the global exchange of perspectives, emphasizing both regional challenges and international health priorities.

Through this vision, JIID aspires to accelerate scientific progress, influence healthcare practices, and inform public health strategies that safeguard populations against both endemic and epidemic threats.

✦ Scope

JIID publishes original research articles, reviews, case studies, perspectives, and policy analyses that address a wide range of themes, including but not limited to:

✦ Immunology

• Mechanisms of innate and adaptive immunity
• Immune cell signaling, regulation, and dysfunction
• Immunopathology in infectious and non-infectious diseases
• Advances in immunotherapies, monoclonal antibodies, and biologics
• Autoimmunity, hypersensitivity, and immune tolerance

✦ Infectious Diseases

• Bacterial, viral, fungal, and parasitic infections
• Emerging and re-emerging infectious diseases (including zoonotic threats)
• Antimicrobial and antiviral resistance: molecular insights and global implications
• Host–pathogen interactions and co-infections
• Clinical management, diagnostics, and therapeutic innovations

✦ Vaccines & Therapeutics

• Vaccine design, development, and deployment strategies
• Next-generation immunization approaches (mRNA, vector-based, nanotechnology-driven platforms)
• Immunoprophylaxis and therapeutic interventions in infectious diseases
• Evaluation of vaccine safety, efficacy, and immunogenicity

✦ Global & Public Health Dimensions

• Epidemiology and disease surveillance
• Outbreak preparedness, response, and policy frameworks
• Health disparities and regional challenges in immunity and infections
• Strategies for strengthening healthcare systems against pandemics
• Integration of immunology into One Health perspectives

✦ Emerging Interdisciplinary Areas

• Computational immunology and systems biology in infectious disease modeling
• Role of microbiome and immunometabolism in host defense
• Immunogenomics, biomarkers, and precision medicine approaches
• Nanotechnology, biotechnology, and bioengineering applications in immune and infectious disease research

✦ Commitment to Impact

The scope of JIID extends beyond traditional academic boundaries. The journal prioritizes work with translational value, ensuring that discoveries are not confined to laboratories but contribute meaningfully to clinical practice, public health policy, and global disease prevention strategies.

By providing a platform for diverse voices and research approaches, JIID seeks to accelerate innovation, promote inclusivity, and foster resilience in the global fight against infectious diseases.